Your browser doesn't support javascript.
loading
Patient-derived tumor organoids to model drug response in gastric cancer.
Vistoso Monreal, Anette; Zhao, Hua; Sedghizadeh, Parish P; Lin, De-Chen.
Afiliación
  • Vistoso Monreal A; Department of Diagnostic Sciences, Anesthesia & Emergency Medicine, Infection and Immunity Laboratory, Herman Ostrow School of Dentistry, University of Southern California, Los Angeles, CA, USA.
  • Zhao H; Center for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry, University of Southern California, Los Angeles, CA, USA.
  • Sedghizadeh PP; Department of Diagnostic Sciences, Anesthesia & Emergency Medicine, Infection and Immunity Laboratory, Herman Ostrow School of Dentistry, University of Southern California, Los Angeles, CA, USA. Electronic address: sedghiza@usc.edu.
  • Lin DC; Center for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry, University of Southern California, Los Angeles, CA, USA. Electronic address: dechenli@usc.edu.
Cell Rep Med ; 5(7): 101650, 2024 Jul 16.
Article en En | MEDLINE | ID: mdl-39019014
ABSTRACT
Gastric cancer poses diverse treatment challenges due to its high tumor heterogeneity. Through the use of patient-derived tumor organoid (PDO) models, new research1 has identified genes and molecular signatures that are predictive of chemotherapeutic response, providing valuable insights for clinical management and translational advancements.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Organoides Límite: Humans Idioma: En Revista: Cell Rep Med Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Organoides Límite: Humans Idioma: En Revista: Cell Rep Med Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
...